FDG-PET may aid treatment decisions for prostate cancer

07/2/2013 | Renal and Urology News

A study presented at a urological meeting found that in patients with prostate cancer, FDG uptake by the prostate as seen on PET scans may be useful for determining whether to treat with radical prostatectomy. "Since there is a high failure rate with prostatectomy, the presence or absence of FDG uptake can help you decide whether to still do a radical prostatectomy in a morbid patient or just reorient the patient to radiation therapy or androgen deprivation therapy," said lead researcher Dr. Frederic Pouliot from Laval University in Quebec. The team compared results from FDG-PET imaging with those from surgery.

View Full Article in:

Renal and Urology News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Accreditation
Meridian Health Plan
Detroit, MI
Stop Loss Sales Executive, (Southern Region)
Indigo Insurance Services
Multiple Locations, SL_Multiple Locations
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC